Tag:
insulin
Latest Headlines
Latest Headlines
Novo confident that it can crack blockbuster oral insulin market
Novo Nordisk says it's willing to bet $2 billion that it can score a mega-blockbuster success in the field.
D. Medical signs worldwide marketing deal for insulin-delivery tech
Israel's D. Medical has signed an original equipment manufacturer agreement with a Korean firm to market its insulin-delivery technology.
Researchers cure Type 1 diabetes in mice
A dose of antibodies, a bone marrow transplant and treatment with pancreas growth factor helped cure late-stage Type 1 diabetes in mice, researchers have found.
Salk scientists eye 2 new targets against Type 2 diabetes
Salk Institute experts and others have identified two new potential drug targets to treat insulin-resistant type 2 diabetes.
Third Rock provides $34M bankroll for an obesity/diabetes startup
Boston-based Third Rock Ventures has committed a $34 million chunk of its funds to a biotech upstart that promises to take some new insights into brown fat and insulin sensitivity and turn them into
Sanofi criticizes study flagging Lantus cancer risk
Another study has drawn links between Sanofi's ( $SNY ) insulin drug Lantus and cancer. But the French drugmaker is pointing out potential flaws in that research, including the "small" number of
Artificial pancreas draft guidance could hurt Medtronic, others
FDA, industry and diabetes advocates may be heading for a clash over regulators' draft guidance for investigators and manufacturers on the development of artificial pancreas devices. The Los Angeles
Novo staffs up in Latin America for modern insulin push
The way things are going in Europe these days, drugmakers are well advised to look elsewhere, and most of them are. As Novo Nordisk plays out scenarios for the eurozone--if the currency collapses,
Biocon seeking rich partner for insulin pill development
Diabetes patients currently inject their insulin, of course. But India's Biocon sees opportunity in developing an oral insulin pill, despite a late-stage clinical trial setback this year for its
Biocon chief vows near-term pact on oral insulin
The high-profile CEO of India's Biocon says that she's closing in on a big-name pharma partner for the company's oral insulin program. Kiran Mazumdar-Shaw told Reuters that "we are in advanced
